Director, Real World Evidence (RWE)

Director of US Real-World Evidence (RWE)

Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ - the skin - meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin, we are in shapes our lives, we are advancing dermatology for every skin story.

We look for people who focus on getting results, embrace learning and bring a positive energy. They must combine initiative with a sense of teamwork and collaboration. Above all, they must be passionate about doing something meaningful for consumers, patients, and the healthcare professionals we serve every day. We aim to empower each employee and promote their personal growth while ensuring business needs are met now and into the future. Across our company, we embrace diversity and respect the dignity, privacy, and personal rights of every employee.

At Galderma, we actively give our teams reasons to believe in our bold ambition to become the leading dermatology company in the world. With us, you have the ultimate opportunity to gain new and challenging work experiences and create an unparalleled, direct impact.

We are seeking a strategic and scientifically driven Director of US Real-World Evidence (RWE) to lead the development and execution of US-focused RWE strategies that support the value proposition of Galderma's marketed product, Nemolizumab, across its lifecycle. This US-centric role will collaborate cross-functionally to generate impactful evidence that informs clinical practice and demonstrates continued value to US HCPs / KOLs and payers. As the sole US RWE leader and expert within Galderma, the candidate will provide exceptional leadership for strategic projects under their direct responsibility. They will also oversee the planning and execution of RWE projects conducted by external vendors.

Key Responsibilities :

RWE Strategy Development :

• Lead, design, and deliver the US RWE strategy for Nemolizumab in alignment with medical affairs and brand objectives, while prioritizing HCP and payer needs in accordance with governance within Galderma.
• Identify and prioritize strategic US evidence gaps in close collaboration with US cross functional team Medical, Market Access, US commercial sales and marketing.

Study Design & Execution :

Cross-Functional Collaboration :

External Engagement :

External Communication :

Data Governance & Compliance :

Qualifications :

What We Offer In Return :

You will be working for an organization that embraces diversity & inclusion and believe we will deliver better outcomes by reflecting the perspectives of our diverse customer base. You will also have access to a range of company benefits, including a competitive wage with shift differential, annual bonus opportunities and career advancement and cross-training.

Next Steps :

Our people make a difference. At Galderma, you'll work with people who are like you. And people that are different. We value what every member of our team brings. Professionalism, collaboration, and a friendly, supportive ethos is the perfect environment for people to thrive and excel in what they do.

Employer's Rights : This job description does not list all the duties of the job. You may be asked by your supervisors or managers to perform other duties. You will be evaluated in part based on your performance of the tasks listed in this job description. The employer has the right to revise this job description at any time. This job description is not an employment contract, and either you or the employer may terminate employment at any time, for any reason. In addition, reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions of this position.